← FDA Drug Approvals (Drugs@FDA)

BUDESONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-11-16

Drug application

FDA Application #

ANDA205710

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUDESONIDE

Generic name

BUDESONIDE

Active ingredients

BUDESONIDE

Dosage form

SUSPENSION

Route

INHALATION

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2017-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown